Samantha Suriano

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

John Wrangle, Vamsidhar Velcheti, Manish R. Patel et al. · The Lancet Oncology · 2018 · 410 citations

Il-15 Superagonist, Medicine, Immunology +8

IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy

Ee Wern Su, Caitlin J. Moore, Samantha Suriano et al. · Science Translational Medicine · 2015 · 61 citations · Full text

Adaptive Immune System, T-regulatory Cell, Immune Regulation +23

Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8+ T cells

Mark P. Rubinstein, Ee Wern Su, Samantha Suriano et al. · Cancer Immunology Immunotherapy · 2015 · 42 citations · Full text

Inflammation, Cytokine, Cancer Immunosurveillance +9

Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells

Christopher Johnson, Bennett R. May, Brian Riesenberg et al. · Cancer Research · 2018 · 13 citations · Full text

IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells

Kristina Andrijauskaite, Samantha Suriano, Colleen Cloud et al. · Cancer Gene Therapy · 2015 · 12 citations · Full text

Inflammation, Autoimmune Disease, T-regulatory Cell +12